Table 1. Overall analysis of R allele in ACTN3 R577X polymorphism with power sports.
Test of association | Test of heterogeneity | Test of association | Test of heterogeneity | Effect of outlier treatment | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | OR | 95% CI | CID | Pa | Sports Performance | Pb | I2 (%) | AM | n | OR | 95% CI | CID | Pa | Sports Performance | Pb | I2 (%) | AM | Signi-ficance | Hetero geneity | |
PRO | PSO | |||||||||||||||||||
Overall power | ||||||||||||||||||||
R | 44 | 1.21 | 1.07–1.37 | 0.30 | 0.002 | MP | 10−5 | 61 | RE | 39 | 1.20 | 1.12–1.30 | 0.18 | 10−5 | MP | 0.10 | 23 | F | ES | RH |
X | 44 | 0.71 | 0.62–0.82 | 0.20 | 10−5 | MC | 0.01 | 35 | RE | 42 | 0.71 | 0.64–0.79 | 0.15 | 10−5 | MC | 0.11 | 22 | F | --- | --- |
RX | 44 | 0.90 | 0.80–1.01 | 0.21 | 0.08 | MC | 10−5 | 62 | RE | 38 | 0.96 | 0.89–1.04 | 0.15 | 0.30 | MC | 0.10 | 24 | F | --- | --- |
Western | ||||||||||||||||||||
R | 31 | 1.11 | 1.01–1.22 | 0.21 | 0.02 | MP | 10−4 | 60 | RE | 28 | 1.12 | 1.02–1.23 | 0.21 | 0.01 | MP | 0.22 | 16 | F | RS | RH |
X | 31 | 0.78 | 0.65–0.92 | 0.27 | 0.004 | MC | 0.02 | 39 | RE | 30 | 0.81 | 0.71–0.92 | 0.21 | 0.001 | MC | 0.13 | 23 | F | --- | --- |
RX | 31 | 0.93 | 0.80–1.07 | 0.27 | 0.31 | MC | 10−5 | 63 | RE | 28 | 1.03 | 0.95–1.13 | 0.18 | 0.45 | Null | 0.12 | 25 | F | RNS | RH |
Asian | ||||||||||||||||||||
R | 9 | 0.83 | 0.48–1.43 | 0.95 | 0.49 | MC | 10−5 | 92 | RE | 7 | 1.11 | 0.65–1.89 | 1.29 | 0.69 | MP | 10−5 | 88 | RE | RNS | NC |
X | 9 | 0.63 | 0.47–0.83 | 0.36 | 0.001 | MC | 0.01 | 60 | RE | 7 | 0.72 | 0.56–0.92 | 0.36 | 0.008 | MC | 0.09 | 45 | RE | --- | --- |
RX | 9 | 1.43 | 0.86–2.39 | 1.53 | 0.17 | MP | 10−5 | 95 | RE | 7 | 1.91 | 1.25–2.92 | 1.67 | 0.003 | MP | 10−5 | 91 | RE | GS | NC |
African | ||||||||||||||||||||
R | 4 | 1.03 | 0.76–1.40 | 0.64 | 0.83 | Null | 0.52 | 0 | F | --- | --- | ------- | --- | --- | --- | --- | --- | --- | --- | --- |
X | 4 | 0.81 | 0.34–1.95 | 1.61 | 0.64 | MC | 0.80 | 0 | F | --- | --- | ------- | --- | --- | --- | --- | --- | --- | --- | --- |
RX | 4 | 0.99 | 0.73–1.36 | 0.63 | 0.96 | Null | 0.48 | 0 | F | --- | --- | ------- | --- | --- | --- | --- | --- | --- | --- | --- |
R: common allele; X: variant allele; RX: heterozygous genotype; n: number of studies; OR: odds ratio; CI: confidence interval; CID: confidence interval difference; Pa: P-value for association; Pb: P-value for heterogeneity; I2: measure of inconsistency expressed in %; AM: analysis model; PRO: pre-outlier; PSO: post-outlier; F: fixed-effects; RE: random-effects; MP: more in power; MC: more in control; Null (ORs 0.97–1.03); values in bold indicate significant effects on sports performance only (OR > 1.00); the significance and heterogeneity columns were filled when one or both OR values in PRO and/or PSO was MP, otherwise the columns were dashed; ES: elevated significance; RS: retained significance; RNS: retained non-significance; GS: gain in significance; RH: reduced heterogeneity; NC: no change